Charles Sang
Keine laufenden Positionen mehr
Karriereverlauf von Charles Sang
Ehemalige bekannte Positionen von Charles Sang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Corporate Officer/Principal | 01.04.2016 | 09.04.2020 |
| NS WIND DOWN CO., INC. | Corporate Officer/Principal | 01.11.2012 | 01.04.2016 |
| SEAGEN INC. | Vertrieb & Marketing | 01.07.2010 | 01.11.2012 |
Ausbildung von Charles Sang
| National-Louis University | Undergraduate Degree |
| New Mexico State University | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Health Technology |
| NS WIND DOWN CO., INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Börse
- Insiders
- Charles Sang
- Erfahrung
